243 related articles for article (PubMed ID: 15476939)
1. Urocortins as cardiovascular peptides.
Takahashi K; Totsune K; Murakami O; Shibahara S
Peptides; 2004 Oct; 25(10):1723-31. PubMed ID: 15476939
[TBL] [Abstract][Full Text] [Related]
2. Physiological roles of urocortins, human homologues of fish urotensin I, and their receptors.
Suda T; Kageyama K; Sakihara S; Nigawara T
Peptides; 2004 Oct; 25(10):1689-701. PubMed ID: 15476936
[TBL] [Abstract][Full Text] [Related]
3. Urocortins and corticotropin releasing factor type 2 receptors in the hypothalamus and the cardiovascular system.
Hashimoto K; Nishiyama M; Tanaka Y; Noguchi T; Asaba K; Hossein PN; Nishioka T; Makino S
Peptides; 2004 Oct; 25(10):1711-21. PubMed ID: 15476938
[TBL] [Abstract][Full Text] [Related]
4. Urocortins and the regulation of gastrointestinal motor function and visceral pain.
Martinez V; Wang L; Million M; Rivier J; Taché Y
Peptides; 2004 Oct; 25(10):1733-44. PubMed ID: 15476940
[TBL] [Abstract][Full Text] [Related]
5. Urocortin expression in rat brain: evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors.
Bittencourt JC; Vaughan J; Arias C; Rissman RA; Vale WW; Sawchenko PE
J Comp Neurol; 1999 Dec; 415(3):285-312. PubMed ID: 10553117
[TBL] [Abstract][Full Text] [Related]
6. Modulation of Ca2+ influx by corticotropin-releasing factor (CRF) family of peptides via CRF receptors in rat pancreatic beta-cells.
Kageyama K; Kimura R; Suga S; Ogawa Y; Suda T; Wakui M
Peptides; 2006 Jul; 27(7):1814-9. PubMed ID: 16513211
[TBL] [Abstract][Full Text] [Related]
7. Peptide ligand binding properties of the corticotropin-releasing factor (CRF) type 2 receptor: pharmacology of endogenously expressed receptors, G-protein-coupling sensitivity and determinants of CRF2 receptor selectivity.
Hoare SR; Sullivan SK; Fan J; Khongsaly K; Grigoriadis DE
Peptides; 2005 Mar; 26(3):457-70. PubMed ID: 15652653
[TBL] [Abstract][Full Text] [Related]
8. Corticotropin-releasing factor receptors and urocortins, links between the brain and the heart.
Yang LZ; Tovote P; Rayner M; Kockskämper J; Pieske B; Spiess J
Eur J Pharmacol; 2010 Apr; 632(1-3):1-6. PubMed ID: 20132811
[TBL] [Abstract][Full Text] [Related]
9. Possible involvement of corticotropin-releasing factor receptor signaling on vascular inflammation.
Inada Y; Ikeda K; Tojo K; Sakamoto M; Takada Y; Tajima N
Peptides; 2009 Feb; 30(2):365-72. PubMed ID: 19026699
[TBL] [Abstract][Full Text] [Related]
10. Urocortin 3/stresscopin in human colon: possible modulators of gastrointestinal function during stressful conditions.
Saruta M; Takahashi K; Suzuki T; Fukuda T; Torii A; Sasano H
Peptides; 2005 Jul; 26(7):1196-206. PubMed ID: 15949638
[TBL] [Abstract][Full Text] [Related]
11. Widespread tissue distribution and diverse functions of corticotropin-releasing factor and related peptides.
Boorse GC; Denver RJ
Gen Comp Endocrinol; 2006 Mar; 146(1):9-18. PubMed ID: 16413023
[TBL] [Abstract][Full Text] [Related]
12. Novel action of pituitary urocortin 2 in the regulation of expression and secretion of gonadotropins.
Nemoto T; Yamauchi N; Shibasaki T
J Endocrinol; 2009 Apr; 201(1):105-14. PubMed ID: 19193717
[TBL] [Abstract][Full Text] [Related]
13. Central stresscopin modulates cardiovascular function through the adrenal medulla in conscious rats.
Chu CP; Qiu DL; Kato K; Kunitake T; Watanabe S; Yu NS; Nakazato M; Kannan H
Regul Pept; 2004 Jun; 119(1-2):53-9. PubMed ID: 15093697
[TBL] [Abstract][Full Text] [Related]
14. Mediation of burn-induced hypermetabolism by CRF receptor-2 activity.
Chance WT; Dayal R; Friend LA; Thomas I; Sheriff S
Life Sci; 2007 Feb; 80(11):1064-72. PubMed ID: 17222429
[TBL] [Abstract][Full Text] [Related]
15. Placental urocortins and CRF in late gestation.
Pepels PP; Spaanderman ME; Bulten J; Smits PB; Hermus AR; Lotgering FK; Sweep CG
Placenta; 2009 Jun; 30(6):483-90. PubMed ID: 19359038
[TBL] [Abstract][Full Text] [Related]
16. Involvement of the corticotropin-releasing factor (CRF) type 2 receptor in CRF-induced thyrotropin release by the amphibian pituitary gland.
Okada R; Miller MF; Yamamoto K; De Groef B; Denver RJ; Kikuyama S
Gen Comp Endocrinol; 2007 Feb; 150(3):437-44. PubMed ID: 17188689
[TBL] [Abstract][Full Text] [Related]
17. Expression of urocortin and corticotropin-releasing factor receptor subtypes in the human heart.
Kimura Y; Takahashi K; Totsune K; Muramatsu Y; Kaneko C; Darnel AD; Suzuki T; Ebina M; Nukiwa T; Sasano H
J Clin Endocrinol Metab; 2002 Jan; 87(1):340-6. PubMed ID: 11788672
[TBL] [Abstract][Full Text] [Related]
18. Endogenous expression and in vitro study of CRF-related peptides and CRF receptors in the rat gastric antrum.
Porcher C; Peinnequin A; Pellissier S; Meregnani J; Sinniger V; Canini F; Bonaz B
Peptides; 2006 Jun; 27(6):1464-75. PubMed ID: 16337313
[TBL] [Abstract][Full Text] [Related]
19. Ancient evolution of stress-regulating peptides in vertebrates.
Chang CL; Hsu SY
Peptides; 2004 Oct; 25(10):1681-8. PubMed ID: 15476935
[TBL] [Abstract][Full Text] [Related]
20. Corticotropin-releasing factor receptor type 1, but not type 2, in the ventromedial hypothalamus modulates dopamine release in female rats.
Muramatsu T; Inoue K; Iwasaki S; Yamauchi T; Hayashi T; Kiriike N
Pharmacol Biochem Behav; 2006 Oct; 85(2):435-40. PubMed ID: 17109941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
